Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12620067rdf:typepubmed:Citationlld:pubmed
pubmed-article:12620067lifeskim:mentionsumls-concept:C0003209lld:lifeskim
pubmed-article:12620067lifeskim:mentionsumls-concept:C1533698lld:lifeskim
pubmed-article:12620067lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:12620067lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:12620067lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:12620067lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:12620067pubmed:issue6lld:pubmed
pubmed-article:12620067pubmed:dateCreated2003-3-6lld:pubmed
pubmed-article:12620067pubmed:abstractTextThe discovery of a novel class of nitric oxide synthase (NOS) inhibitors, 2-substituted 1,2-dihydro-4-quinazolinamines, and the related 4'-aminospiro[piperidine-4,2'(1'H)-quinazolin]-4'-amines is described. Members of both series exhibit nanomolar potency and high selectivity for the inducible isoform of the enzyme (i-NOS) relative to the constitutive isoforms in vitro. Efficacy in acute and chronic animal models of inflammatory disease following oral administration has also been demonstrated using these compounds.lld:pubmed
pubmed-article:12620067pubmed:languageenglld:pubmed
pubmed-article:12620067pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:citationSubsetIMlld:pubmed
pubmed-article:12620067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12620067pubmed:statusMEDLINElld:pubmed
pubmed-article:12620067pubmed:monthMarlld:pubmed
pubmed-article:12620067pubmed:issn0022-2623lld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:WallaceAlan...lld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:TinkerAlan...lld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:BeatonHaydn...lld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:Boughton-Smit...lld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:CookTony RTRlld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:CooperSally...lld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:Fraser-RaeLyn...lld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:HallamKayKlld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:HamleyPeterPlld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:McInallyTomTlld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:NichollsDavid...lld:pubmed
pubmed-article:12620067pubmed:authorpubmed-author:PimmAusten...lld:pubmed
pubmed-article:12620067pubmed:issnTypePrintlld:pubmed
pubmed-article:12620067pubmed:day13lld:pubmed
pubmed-article:12620067pubmed:volume46lld:pubmed
pubmed-article:12620067pubmed:ownerNLMlld:pubmed
pubmed-article:12620067pubmed:authorsCompleteYlld:pubmed
pubmed-article:12620067pubmed:pagination913-6lld:pubmed
pubmed-article:12620067pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:meshHeadingpubmed-meshheading:12620067...lld:pubmed
pubmed-article:12620067pubmed:year2003lld:pubmed
pubmed-article:12620067pubmed:articleTitle1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.lld:pubmed
pubmed-article:12620067pubmed:affiliationDepartment of Medicinal Chemistry, AstraZeneca R & D Charnwood, Bakewell Road, Loughborough, Leicestershire LE11 5RH, UK. Alan.C.Tinker@Astrazeneca.comlld:pubmed
pubmed-article:12620067pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:12620067lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12620067lld:pubmed